Trial intelligence / Profile preview

SWT and PRP for Microvascular Erectile Dysfunction

NCT05048667Phase 1Completed

Sponsor
University of Miami
Start
Jun 2022
Primary completion
Mar 2025
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in erectile dysfunction (ED) comparing SWT plus PRP Group with Sham SWT plus Placebo Saline Group (2 arms). Primary endpoint: Number of Participants With Treatment Emergent Serious Adverse Events at Month 3. Started Jun 2022; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT05048667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05048667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call